Do you want to read an article? Please log in or register.
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort
Related content
COMMENTED
Endocrine and Neuroendocrine Tumors (NET)Lung, Respiratory and Thoracic Cancer
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
★ 1
Recommended and commented by
PD Dr Sara De Dosso, Faculty Member
Transl Lung Cancer Res.
Lantuejoul S, Fernandez-Cuesta L, Damiola F, Girard N, McLeer A
doi: 10.21037/tlcr-20-269.
Genitourinary Cancer
Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate
Oncotarget.
Apostolidis L, Nientiedt C, Winkler EC, Berger AK, Kratochwil C, Kaiser A, Becker AS, Jäger D, Hohenfellner M, Hüttenbrink C, Pahernik S, Distler FA, Grüllich C
doi: 10.18632/oncotarget.26523.
Endocrine and Neuroendocrine Tumors (NET)
Epigenetic EGFR gene repression confers sensitivity to therapeutic BRAFV600E blockade in colon neuroendocrine carcinomas
Clin Cancer Res.
Capdevila J, Arqués O, Hernandez Mora JR, Matito J, Caratu G, Mancuso FM, Landolfi S, Barriuso J, Jimenez-Fonseca P, Lopez Lopez C, Garcia-Carbonero R, Hernando J, Matos I, Paolo N, Hernández-Losa J, Esteller M, Martínez-Cardús A, Tabernero J, Vivancos A, Palmer HG
doi: 10.1158/1078-0432.CCR-19-1266.
Endocrine and Neuroendocrine Tumors (NET)
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Eur J Cancer
Hadoux J, Kanaan C, Durand A, Hescot S, Hautefeuille V, Cadiot G, Tauveron I, Laboureau S, Cao CD, Walter T, Petorin C, Blanchet O, Jannin A, Gu C, Faron M, Leteurtre E, Rousselet MC, Zakeyh JJ, Marchal A, Chatelain D, Beaulaton C, Hervieu V, Ducreux M, Scoazec JY, Baudin E
doi: 10.1016/j.ejca.2021.04.030
Lung, Respiratory and Thoracic Cancer
PD-L1 expression in large cell neuroendocrine carcinoma of the lung
Lung Cancer.
Eichhorn F, Harms A, Warth A, Muley T, Winter H, Eichhorn ME
doi: 10.1016/
Gynecologic CancerRadio-Oncology
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
BMC Cancer.
Tempfer CB, Tischoff I, Dogan A, Hilal Z, Schultheis B, Kern P, Rezniczek GA
doi: 10.1186/s12885-018-4447-x.
Endocrine and Neuroendocrine Tumors (NET)
Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A Review
JAMA Oncol
Stelwagen J, de Vries EGE, Walenkamp AME
doi: 10.1001/jamaoncol.2020.8072
Endocrine and Neuroendocrine Tumors (NET)Gastrointestinal Cancer
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
J Clin Oncol.
Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R
doi: 10.1200/JCO.19.00980.
SPECIAL REPORT
Skin Cancer